Updated on 1 October 2026
Horizon Europe EU
Dr hab; Assistant professor at Military Institute of Medicine-National Research Institute
Warsaw, Poland
About
WIM-PIB operates a Clinical Research Support Center (CWBK); establishment: 2021-2025 (financed by Medical Research Agency, budget: PLN 11 616 419/ approx. EUR 2 750 700,00); developed in 2025-2026 under the project “_Strengthening the Scientific and Research Capacity of the Clinical Research Support Center at the Military Medical Institute—National Research Institute_” funded by the Medical Research Agency (ABM)/ National Reconstruction Plan (KPO); budget: PLN 7,499,968.00 (approx.: EUR 1 777 250,00).
In the last 10 years WIM-PIB has conducted 134 commercial clinical trials across 18 fields (e.g. oncology, dermatology, neurology, ophthalmology, rheumatology, endocrinology, cardiology, gastroenterology, hematology, gynecology, otolaryngology, pulmonology, allergology, nephrology, gastroenterology, urology, and radiology) and since 2020 – 20 non-commercial clinical trials.
In the last 10 years WIM-PIB accomplished above 100 research projects for over 430 million PLN. Currently WIM is implementing 88 research projects worth PLN 435 million.
Key initiatives include:
• DIAGNOTROP - infectious diseases in combat settings (24 million PLN/ 5.6 million euros),
• 20 non-commercial clinical trials (over 222 million PLN/ €52 mln),
• Establishment and development of two key research support units in WIM-PIB:
- Clinical Trials Support Centre (18 million PLN/ €4.3 million),
- Regional Digital Medicine Centre (27 million PLN / approximately €6.4 million),
• AMULET – R&D project on telemedicine solutions in the care of patients with heart failure (13 million PLN/ €3.1 million) - in commercialization (IT system and telemedicine devices).
Attached files
Organisation
Similar opportunities
Project cooperation
Hospital Virgen Macarena Data Analytics Unit
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-08 Towards Artificial General Intelligence (AGI) for healthcare
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
Miguel Giraldez
Project Manager and technician at Hospital Universitario Virgen Macarena
Seville, Spain
Project cooperation
Expertise in HORIZON-MISS-2027-02-CANCER-03
Birute Brasiuniene
MD PhD Head of the Center of Medical oncology at National Cancer Center of VULSK at National Cancer Center branch of Vilnius University hospital Santaros clinics
Vilnius, Lithuania
Project cooperation
Empowering neurodegenerative disease trials
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
Chiheb Guerfel
Chief Executive Officer at Poseidon CRO ( Poseidon Research Balkans d.o.o. )
Novi Sad, Serbia